Trial · NCT03386721
Results by group71
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 71
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | NSCLC: Part I Cohort A (QW/Q2W) | 19.2 | 95% Confidence Interval 8.51 to 37.88 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | NSCLC: Part I Cohort B (QW/Q2W) | 6.3 | 95% Confidence Interval 1.73 to 20.15 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | NSCLC: Part I Cohort D, Arm 1 (QW/Q2W) | 0 | 95% Confidence Interval 0.00 to 56.15 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | NSCLC: Part I Cohort D, Arm 2 (Q3W) | 0 | 95% Confidence Interval 0.00 to 43.45 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | NSCLC: Part I Cohort F (Q3W) | 4.8 | 95% Confidence Interval 0.85 to 22.67 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | NSCLC: Part II Cohort E, Arm 1 (QW/Q2W) | 66.7 | 95% Confidence Interval 20.77 to 93.85 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | NSCLC: Part II Cohort E, Arm 2 (Q3W) | 50.0 | 95% Confidence Interval 9.45 to 90.55 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | SCCHN: Part III Cohort G (Q3W) | 18.2 | 95% Confidence Interval 7.31 to 38.52 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | SCCHN: Part III Cohort H (Q3W) | 3.6 | 95% Confidence Interval 0.63 to 17.71 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | ESCC: Part III Cohort I (Q3W) | 21.9 | 95% Confidence Interval 11.02 to 38.75 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | CSCC: Part III Cohort J (Q3W) | 27.3 | 95% Confidence Interval 16.35 to 41.85 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | SCCHN: Part III Cohort K (QW/Q2W) | 4.0 | 95% Confidence Interval 0.71 to 19.54 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | ESCC: Part III Cohort M (QW/Q2W) | 0 | 95% Confidence Interval 0.00 to 65.76 | percentage of participants | |
| Percentage of Participants With Objective Response Rate (ORR) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 | CSCC: Part III Cohort N (QW/Q2W) | 0 | 95% Confidence Interval 0.00 to 79.35 | percentage of participants | |
| Percentage of Participants With Disease Control Rate (DCR) Determined According to RECIST Version 1.1 | NSCLC: Part I Cohort A (QW/Q2W) | 53.8 | 95% Confidence Interval 35.46 to 71.24 | percentage of participants | |
| Percentage of Participants With Disease Control Rate (DCR) Determined According to RECIST Version 1.1 | NSCLC: Part I Cohort B (QW/Q2W) | 62.5 | 95% Confidence Interval 45.25 to 77.07 | percentage of participants | |
| Percentage of Participants With Disease Control Rate (DCR) Determined According to RECIST Version 1.1 | NSCLC: Part I Cohort D, Arm 1 (QW/Q2W) | 0 | 95% Confidence Interval 0.00 to 56.15 | percentage of participants | |
| Percentage of Participants With Disease Control Rate (DCR) Determined According to RECIST Version 1.1 | NSCLC: Part I Cohort D, Arm 2 (Q3W) | 20.0 | 95% Confidence Interval 3.62 to 62.45 | percentage of participants | |
| Percentage of Participants With Disease Control Rate (DCR) Determined According to RECIST Version 1.1 | NSCLC: Part I Cohort F (Q3W) | 57.1 | 95% Confidence Interval 36.55 to 75.53 | percentage of participants | |
| Percentage of Participants With Disease Control Rate (DCR) Determined According to RECIST Version 1.1 | NSCLC: Part II Cohort E, Arm 1 (QW/Q2W) | 66.7 | 95% Confidence Interval 20.77 to 93.85 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03386721/results